Vir Biotechnology Inc (VIR)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,590,240 | 2,077,960 | 1,431,850 | 716,852 | 423,942 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,590,240K
= 0.00
The debt-to-equity ratio of Vir Biotechnology Inc has consistently been reported as 0.00 from December 31, 2019, to December 31, 2023. This indicates that the company has not used any debt to finance its operations during these periods, relying entirely on equity to fund its activities. A debt-to-equity ratio of 0.00 signifies a conservative financial structure where the company is not relying on borrowed funds for its operations, which can be seen as a positive sign of financial stability and solvency. However, it's important to note that a debt-to-equity ratio of 0.00 may also indicate potential limitations in leveraging opportunities that debt financing may offer in terms of growth and expansion.
Peer comparison
Dec 31, 2023